ND SB 2378 Cost Analysis (2023)
Cost analysis for provisions relating to preferred networks and mail order pharmacy restrictions and a white bagging prohibition.
IA HF 729 Cost Analysis (2021)
If enacted, IA HF 729 would cost the state $1.2 billion over next 10 years. HF 729 would instittue Any Willing Provider rules and restrict
CA SB 524 Talking Points
Talking points addressing SB 524, a bill aimed at prohibiting PBM steering practices in California.
PBMS are Taking Action to Promote Patient Access to Prescription Drugs During COVID-19 Pandemic
PCMA developed overiew addressing the actions PBMs are taking to address access and affordability of prescription drugs during the COVID-19 pandemic.
AL SB 236 Talking Points (2020)
These talking points address how Alabama Senate Bill 236 will impact private contracts and restrict the tools pharmacy benefit managers use to reduce prescription drug